Sign In
Buy ALNY
$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations
03:07pm, Friday, 13'th Feb 2026
Alnylam Pharmaceuticals has declined nearly 40% from its all-time high, pressured by near-term TTR market dynamics and longer-term profitability concerns. The TTR business will likely remain "noisy" i
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
11:20am, Friday, 13'th Feb 2026
Alnylam tops Q4 earnings estimates but misses on sales despite 85% revenue growth, as booming Amvuttra demand fails to lift shares.
Why Alnylam Pharmaceuticals Stock Slipped Today
07:42pm, Thursday, 12'th Feb 2026
The biotech released its final set of figures for 2025. It had a mixed quarter, despite the recent success of a popular product.
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call Transcript
04:14pm, Thursday, 12'th Feb 2026
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call Transcript
Here's What Key Metrics Tell Us About Alnylam (ALNY) Q4 Earnings
11:01am, Thursday, 12'th Feb 2026
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Stre
Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates
10:11am, Thursday, 12'th Feb 2026
Alnylam Pharmaceuticals (ALNY) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $0.06 per share a year ago.
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress
08:00am, Thursday, 12'th Feb 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and ful
Countdown to Alnylam (ALNY) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
10:17am, Monday, 09'th Feb 2026
Besides Wall Street's top-and-bottom-line estimates for Alnylam (ALNY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy?
11:01am, Thursday, 05'th Feb 2026
Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
08:00am, Thursday, 29'th Jan 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the fourth quarter and
Should You Buy Alnylam Pharmaceuticals Before Feb. 12?
04:44am, Wednesday, 28'th Jan 2026
Alnylam will likely report strong sales growth for Amvuttra in its February quarterly update. Management should also provide news about the initiation of two clinical studies.
Strs Ohio Sells 2,155 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
06:12am, Monday, 26'th Jan 2026
Strs Ohio cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 7.1% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commissi
Wealth Enhancement Advisory Services LLC Boosts Holdings in Alnylam Pharmaceuticals, Inc. $ALNY
05:36am, Monday, 26'th Jan 2026
Wealth Enhancement Advisory Services LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 183.8% during the third quarter, according to its most recent filing with the Secur
Essex LLC Sells 1 Shares of Alnylam Pharmaceuticals Inc (ALNY)
09:17am, Tuesday, 20'th Jan 2026
Summary Essex LLC reduced its stake in Alnylam Pharmaceuticals Inc (ALNY) by 0.18%, selling 1 shares and holding 546 shares valued at about $217,120 as
Allstate Corp Acquires Shares of 4,571 Alnylam Pharmaceuticals, Inc. $ALNY
04:19am, Tuesday, 20'th Jan 2026
Allstate Corp bought a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The
